David C Tully - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David C Tully

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Journal of Medicinal Chemistry|January 16, 2020

Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic SteatohepatitisDonatella Chianelli, Paul V Rucker, Jason Roland, et al.

ACS Medicinal Chemistry Letters|August 23, 2014

Lead optimization of imidazopyrazines: a new class of antimalarial with activity on Plasmodium liver stagesBin Zou, Advait Nagle, Arnab K Chatterjee, et al.

Journal of Medicinal Chemistry|June 8, 2011

Imidazolopiperazines: hit to lead optimization of new antimalarial agentsTao Wu, Advait Nagle, Kelli Kuhen, et al.

Nature|November 29, 2013

Targeting Plasmodium PI(4)K to eliminate malariaCase W McNamara, Marcus Cs Lee, Chek Shik Lim, et al.

Pageof 3

Search research articles

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Journal of Medicinal Chemistry|January 16, 2020

Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic SteatohepatitisDonatella Chianelli, Paul V Rucker, Jason Roland, et al.

ACS Medicinal Chemistry Letters|August 23, 2014

Lead optimization of imidazopyrazines: a new class of antimalarial with activity on Plasmodium liver stagesBin Zou, Advait Nagle, Arnab K Chatterjee, et al.

Journal of Medicinal Chemistry|June 8, 2011

Imidazolopiperazines: hit to lead optimization of new antimalarial agentsTao Wu, Advait Nagle, Kelli Kuhen, et al.

Nature|November 29, 2013

Targeting Plasmodium PI(4)K to eliminate malariaCase W McNamara, Marcus Cs Lee, Chek Shik Lim, et al.

Pageof 3